Beat Acute Myeloid Leukemia 1.0

**Semantic type:** Professional or Occupational Group

**Definition:** A collaborative research program involving 11 academic medical centers working collectively to better understand drugs and drug combinations that should be prioritized for further development within clinical and/or molecular subsets of acute myeloid leukemia (AML) patients. It provides the largest-to-date dataset on primary acute myeloid leukemia samples offering genomic, clinical, and drug response.

**Synonyms:** - BEATAML1.0 - BEATAML1.0-COHORT - Beat Acute Myeloid Leukemia (AML) 1.0